Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search Stock, IPO, MF
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
Stock Report Pdf
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
IPO
Alerts
About
Emcure Pharmaceuticals Ltd.
NSE: EMCURE
|
BSE: 544210
|
ISIN: INE168P01015
|
Industry: Pharmaceuticals
CDSCO Approval
|
Strong Performer, Getting Expensive
1869.8000
-19.40
(
-1.03
%)
NSE
Jul 23, 2026
14:58 PM
Near 52W High of ₹1944.00
Volume:
86,850
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Emcure Pharmaceuticals Ltd.
02 Jul 2024
CDSCO Approval
1869.80
-1.03%
EMCURE PHARMACEUTICALS LTD.
IPO Subscribe:
Emcure Pharmaceuticals Ltd.
by
Ventura
Ventura
IPO NOTE
Emcure Pharmaceuticals Ltd. is trading above all available SMAs
More from Emcure Pharmaceuticals Ltd.
Recommended
Market trades lower, Geojit Fin Serv's board appoints Jones George as MD
Trendlyne Marketwatch |
23 Jul 2026, 02:49PM
Which stocks did superstar investors buy in Q1FY27?
The Baseline |
22 Jul 2026, 05:59PM
Five stocks to buy from analysts this week - July 21, 2026
The Baseline |
21 Jul 2026, 05:05PM